Funding for this research was provided by:
Gérontopôle of Toulouse
French Ministry of Health
Pierre Fabre Research Institute
Exhonit Therapeutics SA
Avid Radiopharmaceuticals Inc
French National Agency for Research (n°ANR-11-LABX-0018-01)
Received: 6 November 2017
Accepted: 3 April 2018
First Online: 25 April 2018
Ethics approval and consent to participate
: Both the MAPT and PET sub-study described in this manuscript were approved by the ethical committee in Toulouse (CPP SOOM II) and have therefore been performed in accordance with the 1964 Declaration of Helsinki and its later amendments. Written consent was obtained from all participants.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.